USP7 - a crucial regulator of cancer hallmarks
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2023-05 · 1878 (3) · 188903
DOI: 10.1016/j.bbcan.2023.188903 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2023-05. Verfasst von Gouranga Saha und 3 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Biology and Inflammatory Disorder Division, Council of Scientific and Industrial Research-Indian Institute of Chemical Biology (CSIR-IICB), TR…. Hauptthemen laut MEDLINE: Neoplasms. Die Arbeit wurde bisher 101-mal zitiert (Crossref) und nennt 245 Literaturangaben. Gefördert von: Department of Science and Technology, Ministry of Science and Technology, India, Council of Scientific and Industrial Research, India, Science and Engineering Research Board.
Abstract (Originalsprache)
Over the course of three decades of study, the deubiquitinase Herpesvirus associated Ubiquitin-Specific Protease/Ubiquitin-Specific Protease 7 (HAUSP/USP7) has gradually come to be recognized as a crucially important molecule in cellular physiology. The fact that USP7 is overexpressed in a number of cancers, including breast, prostate, colorectal, and lung cancers, supports the idea that USP7 is also an important regulator of tumorigenesis. In this review, we discuss USP7's function in relation to the cancer hallmarks described by Hanahan and Weinberg. This post-translational modifier can support increased proliferation, block unfavorable growth signals, stop cell death, and support an unstable cellular genome by manipulating key players in the pertinent signalling circuit. It is interesting to note that USP7 also aids in the stabilization of molecules that support angiogenesis and metastasis. Targeting USP7 has now emerged as a crucial component of USP7 research because pharmacological inhibition of USP7 supports p53-mediated cell cycle arrest and apoptosis. Efficacious USP7 inhibition is currently being investigated in both synthetic and natural compounds, but issues with selectivity and a lack of co-crystal structure have hindered USP7 inhibition from being tested in clinical settings. Moreover, the development of new, more effective USP7 inhibitors and their encouraging implications by numerous groups give us a glimmer of hope for USP7-targeting medications as effective substitutes for hazardous cancer chemotherapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cancer Biology and Inflammatory Disorder Division, Council of Scientific and Industrial Research-Indian Institute of Chemical Biology (CSIR-IICB), TRUE Campus, CN-6, Sector-V, Salt Lake, Kolkata-700091 & 4, Raja S.C. Mu…
- Department of Microbiology, Dhruba Chand Halder College, University of Calcutta, Kolkata, PIN - 743372, India.
Förderung
- Department of Science and Technology, Ministry of Science and Technology, India
- Council of Scientific and Industrial Research, India
- Science and Engineering Research Board
Zitieren
APA
Saha, G., Roy, S., Basu, M., & Ghosh, M. K. (2023). USP7 - a crucial regulator of cancer hallmarks. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1878(3), 188903. https://doi.org/10.1016/j.bbcan.2023.188903
Vancouver
Saha G, Roy S, Basu M, Ghosh MK. USP7 - a crucial regulator of cancer hallmarks. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2023;1878(3):188903. doi:10.1016/j.bbcan.2023.188903
BibTeX
@article{Saha2023,
author = {Saha, Gouranga and Roy, Srija and Basu, Malini and Ghosh, Mrinal K},
title = {USP7 - a crucial regulator of cancer hallmarks},
journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
year = {2023},
volume = {1878},
number = {3},
pages = {188903},
doi = {10.1016/j.bbcan.2023.188903}
}
EUVIMED